Lexicon Pharmaceuticals, Inc. earnings per share and revenue

LXRX earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.13 USD which accounts for 29.29% surprise. Company revenue for the same period amounts to 26.55 M USD despite the estimated figure of 6.48 M USD. Estimated earnings per share for the next quarter are -0.09 USD, and revenue is expected to reach 1.43 M USD. Also watch annual changes over time to get a bigger picture of LXRX earnings per share and revenue dynamics.